{"id":"lipoplus-omegaven","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertriglyceridemia"},{"rate":null,"effect":"Infusion site reactions"},{"rate":null,"effect":"Hepatic steatosis (with prolonged use)"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Lipoplus is a lipid emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil that supplies energy and essential fatty acids. Omegaven is a fish oil-based lipid emulsion rich in omega-3 fatty acids (EPA and DHA) that provides anti-inflammatory benefits and supports cellular function. Together, they deliver balanced lipid nutrition with reduced omega-6 to omega-3 ratios, particularly beneficial in critical illness and parenteral nutrition.","oneSentence":"Lipoplus + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 polyunsaturated fatty acids for parenteral nutrition support.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:34:06.668Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Parenteral nutrition in patients unable to receive adequate enteral nutrition"},{"name":"Critical illness and sepsis (omega-3 supplementation)"},{"name":"Post-operative nutritional support"}]},"trialDetails":[{"nctId":"NCT03149653","phase":"PHASE4","title":"Crossover Study on the Effect of Omegaven in Combination With Different Lipid Emulsions in Home Parenteral Nutrition","status":"COMPLETED","sponsor":"General University Hospital, Prague","startDate":"2012-01-15","conditions":"Parenteral Nutrition","enrollment":24},{"nctId":"NCT00396461","phase":"PHASE4","title":"ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients","status":"TERMINATED","sponsor":"B. Braun Medical SA","startDate":"2006-11","conditions":"Critical Illness","enrollment":212}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lipoplus 20% BBraun Melsungen + Omegaven 10% Fresenius Kabi"],"phase":"marketed","status":"active","brandName":"Lipoplus + Omegaven","genericName":"Lipoplus + Omegaven","companyName":"General University Hospital, Prague","companyId":"general-university-hospital-prague","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Lipoplus + Omegaven is a combination intravenous lipid emulsion that provides essential fatty acids and omega-3 polyunsaturated fatty acids for parenteral nutrition support. Used for Parenteral nutrition in patients unable to receive adequate enteral nutrition, Critical illness and sepsis (omega-3 supplementation), Post-operative nutritional support.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}